Heteroaryl Heterocyclic Compounds and Uses Thereof, Hutchison Medipharma
Summary
EPO published patent application EP4214206A1 for Hutchison Medipharma Limited covering heteroaryl heterocyclic compounds and their therapeutic uses. The patent application covers compounds classified under C07D 471/04 and C07D 487/04 with pharmaceutical applications including anticancer (A61P 35/00) and immunomodulator (A61P 37/00) indications. The application designates all major EPC contracting states across the EU and EFTA.
What changed
EPO published patent application EP4214206A1 for heteroaryl heterocyclic compounds filed by Hutchison Medipharma Limited. The application claims compounds effective as anticancer agents (A61P 35/00) and immunomodulators (A61P 37/00), with priority classifications in heterocyclic chemistry (C07D 471/04, C07D 487/04) and pharmaceutical compositions (A61K 31/4985, A61K 31/381). Designated states include all major European Economic Area countries.
Pharmaceutical companies developing competing heterocyclic therapeutics must consider this patent in freedom-to-operate analyses. Generic drug manufacturers targeting the EU market should monitor the prosecution history for potential design-around opportunities during the nine-month opposition period following publication.
What to do next
- Monitor for patent validation in target European markets
- Review freedom-to-operate for related compound development
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOF
Publication EP4214206A1 Kind: A1 Apr 01, 2026
Applicants
Hutchison Medipharma Limited
Inventors
DAI, Guangxiu, XIAO, Kun
IPC Classifications
C07D 471/04 20060101AFI20240905BHEP C07D 471/14 20060101ALI20240905BHEP C07D 487/04 20060101ALI20240905BHEP A61K 31/4985 20060101ALI20240905BHEP A61K 31/381 20060101ALI20240905BHEP A61P 35/00 20060101ALI20240905BHEP A61P 37/00 20060101ALI20240905BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.